- $9.81m
- -$11.39m
Annual balance sheet for Apollomics, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | |
| Standards: | — | IFRS | IFRS | IFRS |
| Status: | fx Preliminary | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | — | 94.5 | 54.6 | 37.8 |
| Net Total Receivables | — | 0.057 | 0 | — |
| Prepaid Expenses | ||||
| Total Current Assets | — | 99.4 | 55.8 | 39.9 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | — | 1.32 | 1.48 | 0.586 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | — | 123 | 76.5 | 55.4 |
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | — | 13.6 | 12.4 | 13.6 |
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | — | 336 | 525 | 14.2 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Treasury Stock | ||||
| Total Equity | — | -213 | -448 | 41.2 |
| Total Liabilities & Shareholders' Equity | — | 123 | 76.5 | 55.4 |
| Total Common Shares Outstanding |